EUVIMEDEUVIMED entdecken
Crossref

Expression of therapy target molecules in esophagogastric junction and Barrett’s adenocarcinoma

Hiroyuki Abe iD, Masayuki Urabe, Koichi Yagi, Hiroharu Yamashita, Yasuyuki Seto, Tetsuo Ushiku

Gastric Cancer · 2025

DOI: 10.1007/s10120-024-01573-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, 2025. Verfasst von Hiroyuki Abe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. hiabe-tky@g.ecc.u-tokyo.ac.jp. Hauptthemen laut MEDLINE: Adenocarcinoma, Barrett Esophagus, Esophagogastric Junction, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaBarrett EsophagusEsophagogastric JunctionEsophageal NeoplasmsBiomarkers, TumorStomach NeoplasmsHumansFemaleMaleMiddle AgedAgedErb-b2 Receptor Tyrosine KinasesPrognosisAdultAged, 80 and overMolecular Targeted TherapyReceptor, Fibroblast Growth Factor, Type 2ClaudinsB7-H1 AntigenSurvival RateFollow-Up StudiesTissue Array Analysis

Stichwörter der Autor:innen

CLDN18Esophago-gastric junctionFGFR2bHER2PD-L1

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesReceptor, Fibroblast Growth Factor, Type 2ClaudinsB7-H1 AntigenERBB2 protein, humanCLDN18 protein, humanCD274 protein, humanFGFR2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. hiabe-tky@g.ecc.u-tokyo.ac.jp.
  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Gastrointestinal Surgery Division, Department of Surgery, Japanese Red Cross Omori Hospital, Tokyo, Japan.
  • Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Esophageal/Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Hiroyuki Abe

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Abe, H., Urabe, M., Yagi, K., Yamashita, H., Seto, Y., & Ushiku, T. (2025). Expression of therapy target molecules in esophagogastric junction and Barrett’s adenocarcinoma. Gastric Cancer. https://doi.org/10.1007/s10120-024-01573-8

Vancouver

Abe H, Urabe M, Yagi K, Yamashita H, Seto Y, Ushiku T. Expression of therapy target molecules in esophagogastric junction and Barrett’s adenocarcinoma. Gastric Cancer. 2025. doi:10.1007/s10120-024-01573-8

BibTeX
@article{Abe2025,
  author = {Abe, Hiroyuki and Urabe, Masayuki and Yagi, Koichi and Yamashita, Hiroharu and Seto, Yasuyuki and Ushiku, Tetsuo},
  title = {Expression of therapy target molecules in esophagogastric junction and Barrett’s adenocarcinoma},
  journal = {Gastric Cancer},
  year = {2025},
  doi = {10.1007/s10120-024-01573-8}
}
Kostenlos starten →